IBDEI268 ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,36431,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,36431,1,1,0)
 ;;=1^J9033
 ;;^UTILITY(U,$J,358.3,36431,1,3,0)
 ;;=3^Bendamustine HCl 1mg
 ;;^UTILITY(U,$J,358.3,36432,0)
 ;;=J9178^^167^1840^38^^^^1
 ;;^UTILITY(U,$J,358.3,36432,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,36432,1,1,0)
 ;;=1^J9178
 ;;^UTILITY(U,$J,358.3,36432,1,3,0)
 ;;=3^Epirubicin HCl Inj 2mg
 ;;^UTILITY(U,$J,358.3,36433,0)
 ;;=J9305^^167^1840^78^^^^1
 ;;^UTILITY(U,$J,358.3,36433,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,36433,1,1,0)
 ;;=1^J9305
 ;;^UTILITY(U,$J,358.3,36433,1,3,0)
 ;;=3^Pemetrexed Inj 10mg
 ;;^UTILITY(U,$J,358.3,36434,0)
 ;;=J2270^^167^1840^67^^^^1
 ;;^UTILITY(U,$J,358.3,36434,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,36434,1,1,0)
 ;;=1^J2270
 ;;^UTILITY(U,$J,358.3,36434,1,3,0)
 ;;=3^Morphine Sulfate Inj 10mg
 ;;^UTILITY(U,$J,358.3,36435,0)
 ;;=J9267^^167^1840^74^^^^1
 ;;^UTILITY(U,$J,358.3,36435,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,36435,1,1,0)
 ;;=1^J9267
 ;;^UTILITY(U,$J,358.3,36435,1,3,0)
 ;;=3^Paclitaxel Inj 1mg
 ;;^UTILITY(U,$J,358.3,36436,0)
 ;;=J2274^^167^1840^68^^^^1
 ;;^UTILITY(U,$J,358.3,36436,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,36436,1,1,0)
 ;;=1^J2274
 ;;^UTILITY(U,$J,358.3,36436,1,3,0)
 ;;=3^Morphine Sulfate,Preservative-Free,Inj 10mg
 ;;^UTILITY(U,$J,358.3,36437,0)
 ;;=J9025^^167^1840^8^^^^1
 ;;^UTILITY(U,$J,358.3,36437,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,36437,1,1,0)
 ;;=1^J9025
 ;;^UTILITY(U,$J,358.3,36437,1,3,0)
 ;;=3^Azacitidine Inj 1mg
 ;;^UTILITY(U,$J,358.3,36438,0)
 ;;=J9330^^167^1840^87^^^^1
 ;;^UTILITY(U,$J,358.3,36438,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,36438,1,1,0)
 ;;=1^J9330
 ;;^UTILITY(U,$J,358.3,36438,1,3,0)
 ;;=3^Temsirolimus Inj 1mg
 ;;^UTILITY(U,$J,358.3,36439,0)
 ;;=J9355^^167^1840^89^^^^1
 ;;^UTILITY(U,$J,358.3,36439,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,36439,1,1,0)
 ;;=1^J9355
 ;;^UTILITY(U,$J,358.3,36439,1,3,0)
 ;;=3^Trastuzumab Inj 10mg
 ;;^UTILITY(U,$J,358.3,36440,0)
 ;;=P9010^^167^1841^22^^^^1
 ;;^UTILITY(U,$J,358.3,36440,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,36440,1,1,0)
 ;;=1^P9010
 ;;^UTILITY(U,$J,358.3,36440,1,3,0)
 ;;=3^Whole Blood,Ea Unit
 ;;^UTILITY(U,$J,358.3,36441,0)
 ;;=P9012^^167^1841^4^^^^1
 ;;^UTILITY(U,$J,358.3,36441,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,36441,1,1,0)
 ;;=1^P9012
 ;;^UTILITY(U,$J,358.3,36441,1,3,0)
 ;;=3^Cryoprecipitate,Ea Unit
 ;;^UTILITY(U,$J,358.3,36442,0)
 ;;=P9016^^167^1841^18^^^^1
 ;;^UTILITY(U,$J,358.3,36442,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,36442,1,1,0)
 ;;=1^P9016
 ;;^UTILITY(U,$J,358.3,36442,1,3,0)
 ;;=3^RBC Leukocytes Reduced
 ;;^UTILITY(U,$J,358.3,36443,0)
 ;;=P9017^^167^1841^6^^^^1
 ;;^UTILITY(U,$J,358.3,36443,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,36443,1,1,0)
 ;;=1^P9017
 ;;^UTILITY(U,$J,358.3,36443,1,3,0)
 ;;=3^Plasma 1 Donor Frz w/in 8hrs
 ;;^UTILITY(U,$J,358.3,36444,0)
 ;;=P9019^^167^1841^10^^^^1
 ;;^UTILITY(U,$J,358.3,36444,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,36444,1,1,0)
 ;;=1^P9019
 ;;^UTILITY(U,$J,358.3,36444,1,3,0)
 ;;=3^Platelets,Ea Unit
 ;;^UTILITY(U,$J,358.3,36445,0)
 ;;=P9021^^167^1841^20^^^^1
 ;;^UTILITY(U,$J,358.3,36445,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,36445,1,1,0)
 ;;=1^P9021
 ;;^UTILITY(U,$J,358.3,36445,1,3,0)
 ;;=3^Red Blood Cells,Ea Unit
 ;;^UTILITY(U,$J,358.3,36446,0)
 ;;=P9022^^167^1841^21^^^^1
 ;;^UTILITY(U,$J,358.3,36446,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,36446,1,1,0)
 ;;=1^P9022
 ;;^UTILITY(U,$J,358.3,36446,1,3,0)
 ;;=3^Washed Red Blood Cells,Ea Unit
 ;;^UTILITY(U,$J,358.3,36447,0)
 ;;=P9023^^167^1841^5^^^^1
